Central Park Hematology Oncology is categorized under Oncologists in New York City, NY and active since 2012.
Central Park Hematology Oncology was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Nathaniel Wisch at the company’s single location by writing to 12 East 86th St, New York City, New York NY 10028 or by phoning (212) 861-6660. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Central Park Hematology Oncology |
| Contact Person: | Nathaniel Wisch |
| Address: | 12 East 86th St, New York City, New York 10028 |
| Phone Number: | (212) 861-6660 |
| Website Address: | cpho.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Oncologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Central Park Hematology Oncology was started in 2012 to provide professional Oncologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Nathaniel Wisch for inquiries that concern Central Park Hematology Oncology by calling the company number (212) 861-6660, as your correspondence is most welcome. Additionally, the physical location of the single location of Central Park Hematology Oncology can be found at the coordinates 40.781222,-73.960048 as well as the street address 12 East 86th St in New York City, New York 10028.
For its online presence, you may visit Central Park Hematology Oncology’s website at cpho.com and engage with its social media outlets through on Twitter and on Facebook.